You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study: Effects on Nonmotor Symptoms and Tolerability
|
|---|---|
| Published in |
JAMA Neurology, January 2015
|
| DOI | 10.1001/jamaneurol.2014.2472 |
| Pubmed ID | |
| Authors |
Kara M. Smith, Eli Eyal, Daniel Weintraub |
| Abstract |
Depression, cognitive impairment, and other nonmotor symptoms (NMSs) are common early in Parkinson disease (PD) and may be in part due to disease-related dopamine deficiency. Many patients with PD are treated with antidepressants for NMSs, and the effect of the combination of PD medications that enhance dopamine neurotransmission and antidepressants on NMSs has not been studied. We report the effects of the addition of a monoamine oxidase B inhibitor, rasagiline, to antidepressant treatment in PD. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 25% |
| United Kingdom | 2 | 13% |
| Germany | 1 | 6% |
| Chile | 1 | 6% |
| Libya | 1 | 6% |
| Mexico | 1 | 6% |
| Unknown | 6 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 81% |
| Scientists | 2 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 207 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Canada | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 203 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 14% |
| Student > Bachelor | 27 | 13% |
| Researcher | 23 | 11% |
| Student > Ph. D. Student | 21 | 10% |
| Student > Doctoral Student | 15 | 7% |
| Other | 42 | 20% |
| Unknown | 50 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 66 | 32% |
| Neuroscience | 21 | 10% |
| Psychology | 15 | 7% |
| Agricultural and Biological Sciences | 9 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Other | 24 | 12% |
| Unknown | 64 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2015.
All research outputs
#1,232,512
of 25,373,627 outputs
Outputs from JAMA Neurology
#1,400
of 5,841 outputs
Outputs of similar age
#16,126
of 359,528 outputs
Outputs of similar age from JAMA Neurology
#19
of 82 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,528 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.